Chiauranib
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer (NCT04921527) | Chipscreen Biosciences, Ltd. | 2021-12-20 |
Track Chiauranib automatically
Every clearance here is in the API, with alerts when new ones post.